Skip to content
Dawon
Pharmaceutical and Biotech

Protecting Research, Production, and Product Integrity

Pharmaceutical and biotechnology operations depend on interconnected laboratories, manufacturing systems, regulated data, facility infrastructure, and external partners. Dawon provides operational intelligence, threat detection, risk management, incident readiness and response across these environments while supporting product quality, data integrity, and continuity of supply.

  • Research Laboratories
  • Process Development
  • Manufacturing
  • Quality Control
  • Packaging and Serialization
  • Clean Utilities
  • Cold Chain
The Regulated Operating Environment

Securing Regulated Pharmaceutical Operations

In pharmaceutical and biotechnology environments, a cyber incident can affect more than system availability. Unauthorized changes may compromise batch consistency, research data, quality records, environmental conditions, or the evidence required for product release.

Cybersecurity must be integrated with quality, validation, engineering, manufacturing, and laboratory processes.

Three gowned operators working in a cleanroom corridor, one seated at a bench, one at the control panel of a filling machine and one at a laminar flow cabinet
What the environment imposes
  • Validated Systems and Controlled Change

    Systems supporting regulated processes are validated for their intended use. Security updates, configuration changes, segmentation, and response actions must follow established change control procedures to preserve their validated state.

  • Batch and Process Integrity

    Changes to manufacturing parameters, recipes, equipment configurations, or process data can affect product quality without immediately stopping production. Security monitoring must account for both availability and process integrity.

  • Data Integrity

    Electronic records, audit trails, laboratory results, production data, and electronic signatures support quality decisions and batch release. Unauthorized modification, deletion, or loss of this information can create regulatory and patient safety consequences.

  • Specialized and Long Lived Technology

    Laboratory instruments, production equipment, and facility systems may use proprietary software or unsupported operating systems. They cannot be updated without OEM approval, requalification, or additional validation.

  • Intellectual Property and Research Data

    Drug candidates, biological sequences, formulations, experimental results, manufacturing methods, and clinical research data are high value assets. Their compromise can affect years of research and competitive advantage.

  • Third Party Dependencies

    Contract research organizations, contract manufacturing organizations, laboratory suppliers, equipment manufacturers, cloud providers, and logistics partners may handle critical processes or regulated data.

  • Controlled Environmental Conditions

    Cleanrooms, cold storage, environmental monitoring, purified water, HVAC, and other facility systems maintain conditions required for product quality. Disruption or manipulation may result in lost batches, damaged samples, or unusable inventory.

Continuous Cyber Security Across the Pharmaceutical Lifecycle

Supporting dependencies
  • Laboratory Systems
  • Facility Utilities
  • Suppliers
  • Contract Partners
  • Regulatory Data
  1. Research

    LAB INSTRUMENTS · SAMPLE MANAGEMENT

    THE REGULATED RECORD · STUDY DATA

  2. Process Development

    PILOT SYSTEMS · SCALE UP

    THE REGULATED RECORD · TRANSFER PACKAGE

  3. Manufacturing

    PROCESS CONTROL · RECIPES · BATCH

    THE REGULATED RECORD · BATCH RECORD

  4. Quality Control

    TESTING PLATFORMS · QUALITY SYSTEMS

    THE REGULATED RECORD · TEST RESULTS

  5. Packaging

    FILLING · LABELLING · AGGREGATION

    THE REGULATED RECORD · SERIALIZATION DATA

  6. Cold Chain Distribution

    COLD STORAGE · LOGISTICS PLATFORMS

    THE REGULATED RECORD · TEMPERATURE DATA

Dawon Security Intelligence and Assurance Layer

OPERATIONAL INTELLIGENCE · THREAT DETECTION · RISK MANAGEMENT · INCIDENT READINESS AND RESPONSE

Every stage produces product and produces record. The assurance layer runs continuously beneath both, and the dependencies above reach every stage of each.

Findings in Regulated Context

Security Intelligence for Regulated Operations

Dawon connects cybersecurity findings with regulated processes, product dependencies, quality requirements, and operational consequences.

  • Asset Intelligence

    Develop contextual intelligence across laboratory technology, manufacturing systems, facility infrastructure, quality platforms, and supporting networks. Organize systems by site, department, process, product, validation status, supplier, software version, and relevance.

  • Process and Data Dependency Mapping

    Map how laboratory, production, quality, environmental, and data management systems support regulated activities. Understand how the disruption or compromise of one system could affect a batch, study, product, or release decision.

  • Threat and Change Detection

    Identify suspicious activity, unauthorized access, unexpected communications, and changes affecting regulated laboratory, production, and facility systems. Security events can be correlated with approved maintenance windows, change controls, and established operating procedures to distinguish authorized work from unexpected activity.

  • Validation Aware Exposure Management

    Evaluate exposures according to their potential effect on product quality, data integrity, patient safety, intellectual property, and continuity of supply. Remediation planning accounts for validation requirements, OEM restrictions, production schedules, and available compensating controls.

  • Audit Trail and Configuration Assurance

    Maintain security intelligence across system configurations, software versions, access activity, audit trails, and change histories. This helps identify changes that may affect the trustworthiness of regulated processes and electronic records.

  • Supplier and Remote Access Governance

    Assess how equipment manufacturers, service providers, laboratories, contractors, and external partners connect to regulated environments. Track access paths, responsibilities, system dependencies, and supporting evidence.

  • Incident Readiness for Regulated Operations

    Develop response procedures for ransomware, compromised laboratory systems, unauthorized process changes, data integrity events, facility disruption, and supplier incidents. Response actions account for batch status, validated configurations, evidence preservation, quality investigations, product impact assessment, and regulatory reporting responsibilities.

Applications Across Pharmaceutical and Biotech Operations

Unified Security Across Pharmaceutical Operations

Technical space

Clean Utilities

PURIFIED WATER · CLEAN STEAM · HVAC · REFRIGERATION

PW / WFI · CLEAN STEAM · HVAC

Classified production area · GRADE D CORRIDOR
  • GRADE C

    Process Development

    PILOT SUITES · SCALE UP SKIDS

  • GRADE C

    Manufacturing

    BIOREACTORS · BLENDING · GRANULATION · COATING

    GRADE A / B · ASEPTIC CORE

  • GRADE C

    Packaging

    FILLING · INSPECTION · LABELLING · AGGREGATION

Dawon Operational Intelligence
Controlled support areas
  • R&D Laboratory

    INSTRUMENTS · AUTOMATION · SEQUENCING · SAMPLES

  • Quality Control

    TESTING PLATFORMS · RECORDS · AUDIT TRAILS

  • Cold Storage

    TEMPERATURE MONITORING · WAREHOUSE AUTOMATION

  • Airlock, where personnel or material cross a classification boundary
  • Pressure cascade, running outward from the cleanest zone
Where it applies
  • Research and Automated Laboratories

    Protect laboratory instruments, automation platforms, sample management systems, sequencing environments, scientific data repositories, and supporting research infrastructure.

  • Process Development and Technology Transfer

    Maintain security and configuration integrity as laboratory processes are transferred into pilot, scale up, and commercial manufacturing environments.

  • Pharmaceutical Manufacturing

    Secure systems supporting active pharmaceutical ingredients, formulation, blending, granulation, tableting, coating, and other regulated production processes.

  • Biologics and Advanced Therapies

    Establish security intelligence across bioreactors, purification systems, cell processing environments, analytical platforms, and temperature controlled storage supporting biologics, vaccines, and advanced therapies.

  • Quality Control and Batch Release

    Protect laboratory data, quality systems, electronic batch records, audit trails, testing platforms, and other information used to evaluate and release products.

  • Packaging and Serialization

    Secure filling, inspection, labelling, packaging, aggregation, and serialization environments while protecting the integrity of product identification and traceability data.

  • Cleanrooms and Critical Utilities

    Monitor the systems maintaining environmental conditions, purified water, clean steam, HVAC, refrigeration, power, and other services required for controlled manufacturing.

  • Cold Chain and Distribution

    Protect temperature monitoring, warehouse automation, cold storage, logistics platforms, and distribution systems responsible for maintaining product conditions through delivery.

Operational and Regulatory Outcomes

Outcomes Across Quality, Continuity, and Governance

A stainless filling head lowered over a white bottle travelling on the blue chain conveyor of a packaging line
  • Improved continuity of research, production, and product supply

  • Contextual intelligence across laboratory, manufacturing, and facility systems

  • Risk prioritization based on product quality and process consequences

  • Earlier identification of unauthorized access and system changes

  • Stronger protection of formulations, research data, and manufacturing knowledge

  • Improved governance of suppliers, OEMs, and contract partners

  • Better coordination between cybersecurity, quality, validation, engineering, and operations

  • Faster product impact assessment during security incidents

  • Traceable evidence for investigations, audits, and regulatory inspections

  • Consistent security governance across global and acquired facilities

Dawon delivers structured evidence management aligned with applicable requirements, standards, and industry guidance, including:

  • FDA 21 CFR Part 11electronic records and electronic signatures
  • FDA 21 CFR Parts 210 and 211current Good Manufacturing Practice for drugs
  • FDA Data Integrity and Compliance with Drug CGMP guidance
  • EU GMP Annex 11computerized systems
  • EU GMP Chapter 4documentation
  • MHRA Data Integrity Guidance
  • ISPE GAMP guidance
  • NIST Cybersecurity Framework 2.0
  • NIST SP 800 82 Rev. 3
  • ISA/IEC 62443
  • ISO/IEC 27001
  • NIS2 and applicable national pharmaceutical regulations

Strengthen Cyber Security Across the Product Lifecycle

Protect pharmaceutical and biotechnology operations through a unified security approach designed around product integrity, regulated processes, and continuity of supply.